TVTX FY 2022 Earnings — Travere Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TVTXTravere Therapeutics, Inc.

$3B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$109M-17.0% YoY

Gross Profit

$105M96.0% margin

Operating Income

-$320M-292.2% margin

Net Income

-$278M-254.4% margin

EPS (Diluted)

$-4.37

Cash Flow

Operating Cash Flow

-$186M

Free Cash Flow

-$215M

Stock-Based Comp.

$38M

Balance Sheet

Total Assets

$673M

Total Liabilities

$630M

Stockholders' Equity

$43M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$109M	$132M	-17.0%
Gross Profit	$105M	$128M	-17.9%
Operating Income	-$320M	-$199M	-60.4%
Net Income	-$278M	-$180M	-54.6%